Myocardial infarction, also known as heart attack, occurs due to decreased blood flow to a part of the heart muscle, causing damage. Cardiac imaging solutions such as echocardiogram, MRI, CT scan, angiogram, and nuclear imaging enable visualization of the heart muscle and detection of myocardial infarctions. These solutions provide accurate diagnosis by identifying compromised blood flow and assessing heart muscle damage. The use of cardiac imaging aids in determining appropriate therapy and monitoring of recovery or progression.
The global Myocardial Infarction Market is estimated to be valued at Us$ 2347.22 Bn in 2023 and is expected to exhibit a CAGR Of 22% over the forecast period 2024 To 2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The adoption of cardiac imaging solutions has accelerated growth in the myocardial infarction market. Cardiac imaging is the standard of care for diagnosing myocardial infarction and provides efficient, accurate and timely diagnosis compared to traditional methods. Various techniques such as CT angiography and MRI have proven highly effective in detecting blockages and assessing risk of heart attacks. Advancements have allowed for faster, more detailed scans reducing diagnostic time. Widespread use of imaging modalities has aided clinicians in improving treatment outcomes. Increasing investments by hospitals and diagnostic centers to purchase updated imaging equipment will further drive the market over the forecast period.
Segment Analysis
The global myocardial infarction market is dominated by the diagnostic segment. Within diagnostics, electrocardiography segment holds the largest share due to it being the primary and most common test performed to diagnose myocardial infarction. ECG allows quick detection of abnormal electrical activity in the heart muscles and is widely used in emergency rooms and cardiovascular clinics.
Key Takeaways
The Global Myocardial Infarction Market Demand is expected to witness high growth. The growth is attributed to increasing incidence of cardiovascular diseases, rising geriatric population, growing obesity rates and unhealthy lifestyles.
Regional analysis:
North America currently accounts for the largest share in the global myocardial infarction market due to growing prevalence of heart diseases, rising healthcare spending, presence of advanced healthcare facilities and presence of key players. However, Asia Pacific is expected to grow at the fastest pace during the forecast period owing to improving healthcare infrastructure, rising medical tourism, growing obesity and sedentary lifestyles.
Key players operating in the myocardial infarction market are AT&T Inc., Verizon Communications Inc., NTT Communications Corporation, China Telecom Corporation Limited, Deutsche Telekom AG, British Telecommunications plc (BT), Orange S.A., Telefonica S.A., Sprint Corporation (now part of T-Mobile), CenturyLink (now rebranded as Lumen Technologies), Vodafone Group plc, SoftBank Group Corp., Level 3 Communications, Telstra Corporation Limited, Tata Communications Limited.
Get more insights on this topic :
Comments
0 comment